Silencing of CDX2 Expression in Colon Cancer via a Dominant Repression Pathway

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m307435200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Deregulation of the CDX2-KLF4 Axis in Acute Myeloid Leukemia and Colon Cancer

Oncotarget
Oncology
2013English

UNBS5162 Inhibits Colon Cancer Growth via Suppression of PI3K/Akt Signaling Pathway

Medecine/Sciences
BiochemistryMedicineGeneticsMolecular Biology
2018English

Prognostic Impact of CDX2 in Stage II Colon Cancer: Results From Two Nationwide Cohorts

British Journal of Cancer
Cancer ResearchOncology
2018English

Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2015English

The S100p/Rage Signaling Pathway Regulates Expression of microRNA-21 in Colon Cancer Cells

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2015English

BRAF: A Driver of the Serrated Pathway in Colon Cancer

Cancer Cell
Cancer ResearchOncologyCell Biology
2013English

Arsenic Sulfide Amplifies JQ1 Toxicity via Mitochondrial Pathway in Gastric and Colon Cancer Cells

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Bile Acids Promote Gastric Intestinal Metaplasia by Upregulating CDX2 and MUC2 Expression via the FXR/NF-κB Signalling Pathway

International Journal of Oncology
Cancer ResearchOncology
2019English

Expression of Factors and Key Components Associated With the PI3K Signaling Pathway in Colon Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy